Goldman Sachs’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2
| Closed | -$18K | – | 5355 |
|
|
2022
Q3 | $18K | Buy |
2
+1
| +100% | +$9K | ﹤0.01% | 5188 |
|
|
2022
Q2 | $17K | Hold |
1
| – | – | ﹤0.01% | 5452 |
|
|
2022
Q1 | $98K | Hold |
1
| – | – | ﹤0.01% | 5321 |
|
|
2021
Q4 | $219K | Hold |
1
| – | – | ﹤0.01% | 4948 |
|
|
2021
Q3 | $371K | Buy |
+1
| New | +$371K | ﹤0.01% | 4542 |
|
|
2021
Q2 | – | Hold |
0
| – | -$322K | – | 5274 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4607 |
|
|
2017
Q1 | – | Hold |
0
| – | -$46K | – | 4540 |
|
|
2016
Q4 | – | Hold |
0
| – | -$12K | – | 4235 |
|
|
2016
Q3 | – | Hold |
0
| – | -$25K | – | 4489 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4374 |
|
|
2014
Q1 | – | Hold |
0
| – | -$109K | – | 4402 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4063 |
|